Adjuvant chemotherapy is usually recommended for patients with pT3-4 and/or with lymph node metastasis and no distant metastasis, which requires comprehensive judgment by a medical professional.
Radical cystectomy is usually used to treat: T2-T4a, N0-X, M0 invasive bladder cancer; high-risk non-muscle invasive bladder cancer T1G3 (high-grade) tumors; BCG-naïve Tis; recurrent non-muscle invasive bladder cancers; extensive papillary lesions that cannot be controlled by electrodessication and cystoperfusion, and non-urinary epithelial cancer of the bladder.
Adjuvant chemotherapy is currently recommended for patients with pT3-4 and/or concomitant lymph node metastases and no distant metastases.
Most of the regimens are cisplatin-containing combination chemotherapy, and usually 4-6 courses are completed when conditions permit.
If a bladder tumor is suspected or diagnosed, it is recommended to go to a regular hospital for a comprehensive evaluation of the condition, follow the doctor’s instructions and choose an appropriate treatment plan to avoid delay.